Kıvrak Yüksel, Güvenç Tolga Sinan, Akbulut Nurcihan, Yağcı Ibrahim, Cığşar Gülşen, Gündüz Süleyman, Balcı Bahattin
Department of Psychiatry, Kafkas University School of Medicine, 36000 Kars, Turkey.
Department of Cardiology, Kafkas University School of Medicine, Kars, Turkey.
Case Rep Psychiatry. 2014;2014:659715. doi: 10.1155/2014/659715. Epub 2014 Sep 24.
Venlafaxine is the first antidepressant that acts via inhibiting serotonin and noradrenaline reuptake. Hypertension is observed in doses exceeding 300 mg/day and is the most feared complication. We report a patient with accelerated hypertension after venlafaxine use observed at a dose of 150 mg/day. A 23-year-old patient with symptoms of insomnia, depression, anhedonia, fatigue admitted our clinic. Venlafaxine at a dose of 75 mg/day was initiated after he was diagnosed with major depressive disorder. After 5 months, venlafaxine dose was uptitrated to 150 mg/day due to inadequate response to drug. After using venlafaxine for ten months at the dose of 150 mg/day, he admitted our clinic with headache and epistaxis. He was hospitalized after his blood pressure was measured as 210/170 mmHg. No secondary causes for hypertension were found, and venlafaxine treatment was considered possible etiologic factor. After stopping venlafaxine treatment, his blood pressure was reverted back to normal limits. While mild elevation of blood pressure could be observed after venlafaxine treatment, this case shows that accelerated hypertension with a diastolic blood pressure rise above 120 mmHg could be observed at relatively low doses of venlafaxine. Close monitoring of blood pressure is necessary after initiation of treatment, as accelerated hypertension could cause endorgan damage with potentially catastrophic results.
文拉法辛是第一种通过抑制血清素和去甲肾上腺素再摄取起作用的抗抑郁药。在剂量超过300毫克/天时会观察到高血压,这是最令人担忧的并发症。我们报告了一名患者,在使用剂量为150毫克/天的文拉法辛后出现了高血压急症。一名有失眠、抑郁、快感缺失、疲劳症状的23岁患者入住了我们的诊所。在他被诊断为重度抑郁症后,开始使用剂量为75毫克/天的文拉法辛。5个月后,由于对药物反应不足,文拉法辛剂量上调至150毫克/天。在以150毫克/天的剂量使用文拉法辛10个月后,他因头痛和鼻出血入住我们的诊所。在测量血压为210/170毫米汞柱后,他住院了。未发现高血压的继发原因,文拉法辛治疗被认为是可能的病因。停止文拉法辛治疗后,他的血压恢复到正常范围。虽然在文拉法辛治疗后可能会观察到血压轻度升高,但该病例表明,在相对低剂量的文拉法辛治疗时也可能出现舒张压升高超过120毫米汞柱的高血压急症。治疗开始后有必要密切监测血压,因为高血压急症可能导致终末器官损害,产生潜在的灾难性后果。